Fresh Heart Stent Scandal Rocks KGMU as Probe Expands Amid Cancer Drug Scam Investigation

The CSR Journal Magazine

A fresh controversy has emerged at King George’s Medical University (KGMU) in Lucknow as authorities intensify investigations into alleged irregularities involving heart stent procedures. The inquiry focuses on cardiac treatments carried out over the past year, with officials examining whether multiple stents were unnecessarily implanted in patients under government-funded healthcare schemes.

The investigation gained momentum after allegations surfaced that more than a dozen patients had received as many as five stents each. Authorities are now reviewing treatment records to determine whether medical procedures were justified and whether public funds under the Ayushman Bharat Yojana were misused.

In response, the university administration has sought detailed reports on angiographies, heart surgeries, and other cardiac interventions performed during the review period.

Doctors and Staff Face Scrutiny

As the probe deepens, KGMU has taken several administrative measures to ensure cooperation from those under investigation. Leave granted to doctors linked to the alleged irregularities has reportedly been cancelled, and they have been instructed to remain available for questioning.

Officials are also examining the role of contractual and third-party personnel involved in patient management and billing processes. Preliminary findings have prompted disciplinary action against certain staff members, while proceedings to suspend and blacklist associated agencies are underway.

The university has additionally removed Ayushman Mitras linked to heart stent-related cases and replaced them with regular staff members to strengthen oversight and transparency.

Investigators are collecting feedback from patients who underwent cardiac treatment, while medical records and administrative documents are being verified at multiple levels.

Parallel Probe Into Cancer Drug Purchases

The heart stent investigation comes at a time when KGMU is already facing scrutiny over an alleged cancer drug procurement scam. Authorities launched that inquiry after noticing a sharp rise in expenditure on medicines provided under the Asadhya Yojana.

According to officials, monthly spending on cancer drugs increased significantly within a short period, triggering concerns over procurement practices and possible financial irregularities. Investigators are now reviewing prescription records, medicine distribution logs, and treatment documentation to establish whether public funds were misused.

Several contractual employees have already been removed from service as part of the ongoing inquiry.

Strict Action Promised

University authorities have assured that strict action will be taken against anyone found responsible for wrongdoing. Measures under consideration include recovery of misused funds, termination of employment, blacklisting of vendors, and criminal proceedings where necessary.

As both investigations continue, KGMU faces growing pressure to restore public confidence and strengthen oversight mechanisms within its healthcare and procurement systems.

Long or Short, get news the way you like. No ads. No redirections. Download Newspin and Stay Alert, The CSR Journal Mobile app, for fast, crisp, clean updates!

App Store –  https://apps.apple.com/in/app/newspin/id6746449540 

Google Play Store – https://play.google.com/store/apps/details?id=com.inventifweb.newspin&pcampaignid=web_share

Latest News

Popular Videos